巴雷特食管射频消融后行食管内镜黏膜下剥离术的可行性
该单中心回顾性分析评估了既往接受射频消融(RFA)治疗的巴雷特食管(BE)患者后续行食管内镜黏膜下剥离术(ESD)的可行性。44例食管ESD病例中7例有RFA史,整块切除率100%,R0切除率86%,无急性或迟发不良事件及再住院。结论认为ESD对既往RFA患者可能可行且安全。
要点
- 既往RFA的BE患者行ESD整块切除率达100%,R0切除率86%。
- 7例患者均未发生急性或迟发不良事件,也无再住院。
- ESD可考虑用于既往因BE接受RFA治疗后的食管肿瘤。
核心结论
- ESD对既往接受RFA治疗的BE患者可能是可行且安全的选择。
研究设计与样本
- 单中心回顾性分析,纳入44例食管ESD病例,其中7例既往因BE接受RFA治疗。
主要发现
- 7例既往RFA患者行ESD的整块切除率为100%,R0切除率为86%。
- 7例患者均未发生急性或迟发不良事件,也无再住院。
关键数值与推荐
- 既往RFA患者行ESD的整块切除率为100%,R0切除率为86%。
临床怎么用
- 对既往因BE接受RFA治疗后的食管肿瘤患者,可考虑行ESD。
局限性
- 本研究为单中心回顾性分析,既往RFA后行ESD的病例仅7例。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
BACKGROUND AND AIMS: Radiofrequency ablation (RFA) is a well-established treatment for Barrett's esophagus (BE) in the United States. Similarly, endoscopic submucosal dissection (ESD) has been widely performed for early esophageal carcinoma. However, conducting ESD after RFA can be technically challenging. The aim of this study was to assess the feasibility and safety of ESD in patients with prior RFA. METHODS: This study was a single-center retrospective analysis of patients who underwent esophageal ESD after undergoing prior RFA treatment for BE. RESULTS: Of 44 esophageal ESD cases, 7 underwent prior RFA. In those 7 cases, the en bloc resection rate was 100%, and the R0 resection rate was 86%. No acute or delayed adverse events or rehospitalizations occurred in any patient. CONCLUSIONS: ESD may be a feasible and safe option for patients with a history of RFA. It could be considered for esophageal neoplasms in patients previously treated with RFA for BE.
引用
- Koseki M, Nishimura M, Nammour T, et al. Feasibility of esophageal endoscopic submucosal dissection after radiofrequency ablation treatment in patients with Barrett's esophagus. Gastrointest Endosc. 2024. PMID: 38340874. doi:10.1016/j.gie.2024.02.002
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。